MedPath

The pharmacogenomics approach about MTX-induced leukoencephalopathy

Not Applicable
Conditions
leukoencephalopthy
Registration Number
JPRN-UMIN000020127
Lead Sponsor
Yokohama City University Graduate School of Medicine, Department of Pediatrics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

Not investigated CNS by MRI

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The association MTX-induced leukoencephalopathy and gene after chemotherapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath